4.7 Review

Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention

Journal

Publisher

MDPI
DOI: 10.3390/ijms18050984

Keywords

advanced glycation end-products; diabetes; glyoxalase; aldose reductase; methylglyoxal; glyoxal; 3-deoxyglucosone

Funding

  1. Deutsche Forschungsgemeinschaft (DFG) [SFB1118]
  2. Dietmar Hopp Foundation (DHS)
  3. German Center for Diabetes Research (DZD)

Ask authors/readers for more resources

Advanced glycation end-products (AGEs) are non-enzymatic protein and amino acid adducts as well as DNA adducts which form from dicarbonyls and glucose. AGE formation is enhanced in diabetes and is associated with the development of diabetic complications. In the current review, we discuss mechanisms that lead to enhanced AGE levels in the context of diabetes and diabetic complications. The methylglyoxal-detoxifying glyoxalase system as well as alternative pathways of AGE detoxification are summarized. Therapeutic approaches to interfere with different pathways of AGE formation are presented.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available